Valeant, a Canada-based multinational pharmaceutical company, is to sell the CeraVe, AcneFree and Ambi skincare brands to L’Oréal for $1.3 billion in cash. The CeraVe brand lineup includes cleansers and moisturisers for hand, face and body, as well as baby toiletries, and is based on ceramides, cholesterol and fatty esters delivered through a controlled-release system. The AcneFree range consists of lotions, wipes and other topical anti-acne products, while the Ambi line includes …